Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173833029> ?p ?o ?g. }
- W3173833029 endingPage "e1009132" @default.
- W3173833029 startingPage "e1009132" @default.
- W3173833029 abstract "While advancements in genome sequencing have identified millions of somatic mutations in cancer, their functional impact is poorly understood. We previously developed the expression-based variant impact phenotyping (eVIP) method to use gene expression data to characterize the function of gene variants. The eVIP method uses a decision tree-based algorithm to predict the functional impact of somatic variants by comparing gene expression signatures induced by introduction of wild-type (WT) versus mutant cDNAs in cell lines. The method distinguishes between variants that are gain-of-function, loss-of-function, change-of-function, or neutral. We present eVIP2, software that allows for pathway analysis (eVIP Pathways) and usage with RNA-seq data. To demonstrate the eVIP2 software and approach, we characterized two recurrent frameshift variants in RNF43, a negative regulator of Wnt signaling, frequently mutated in colorectal, gastric, and endometrial cancer. RNF43 WT, RNF43 R117fs, RNF43 G659fs, or GFP control cDNA were overexpressed in HEK293T cells. Analysis with eVIP2 predicted that the frameshift at position 117 was a loss-of-function mutation, as expected. The second frameshift at position 659 has been previously described as a passenger mutation that maintains the RNF43 WT function as a negative regulator of Wnt. Surprisingly, eVIP2 predicted G659fs to be a change-of-function mutation. Additional eVIP Pathways analysis of RNF43 G659fs predicted 10 pathways to be significantly altered, including TNF-α via NFκB signaling, KRAS signaling, and hypoxia, highlighting the benefit of a more comprehensive approach when determining the impact of gene variant function. To validate these predictions, we performed reporter assays and found that each pathway activated by expression of RNF43 G659fs, but not expression of RNF43 WT, was identified as impacted by eVIP2, supporting that RNF43 G659fs is a change-of-function mutation and its effect on the identified pathways. Pathway activation was further validated by Western blot analysis. Lastly, we show primary colon adenocarcinoma patient samples with R117fs and G659fs variants have transcriptional profiles similar to BRAF missense mutations with activated RAS/MAPK signaling, consistent with KRAS signaling pathways being GOF in both variants. The eVIP2 method is an important step towards overcoming the current challenge of variant interpretation in the implementation of precision medicine. eVIP2 is available at https://github.com/BrooksLabUCSC/eVIP2 ." @default.
- W3173833029 created "2021-07-05" @default.
- W3173833029 creator A5002402867 @default.
- W3173833029 creator A5011108891 @default.
- W3173833029 creator A5012343504 @default.
- W3173833029 creator A5023403433 @default.
- W3173833029 creator A5033555764 @default.
- W3173833029 creator A5048568172 @default.
- W3173833029 creator A5049746620 @default.
- W3173833029 creator A5062944849 @default.
- W3173833029 creator A5087046325 @default.
- W3173833029 date "2021-07-02" @default.
- W3173833029 modified "2023-10-18" @default.
- W3173833029 title "eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants" @default.
- W3173833029 cites W1967736480 @default.
- W3173833029 cites W1973012451 @default.
- W3173833029 cites W1980383179 @default.
- W3173833029 cites W1987908519 @default.
- W3173833029 cites W1989277387 @default.
- W3173833029 cites W2001100804 @default.
- W3173833029 cites W2006444511 @default.
- W3173833029 cites W2010457001 @default.
- W3173833029 cites W2021341670 @default.
- W3173833029 cites W2025183726 @default.
- W3173833029 cites W2037900813 @default.
- W3173833029 cites W2078060536 @default.
- W3173833029 cites W2084069370 @default.
- W3173833029 cites W2090789702 @default.
- W3173833029 cites W2102140136 @default.
- W3173833029 cites W2111905790 @default.
- W3173833029 cites W2113224213 @default.
- W3173833029 cites W2114023704 @default.
- W3173833029 cites W2114843025 @default.
- W3173833029 cites W2118017554 @default.
- W3173833029 cites W2121604817 @default.
- W3173833029 cites W2121906867 @default.
- W3173833029 cites W2123937928 @default.
- W3173833029 cites W2130410032 @default.
- W3173833029 cites W2131178190 @default.
- W3173833029 cites W2131796349 @default.
- W3173833029 cites W2141006596 @default.
- W3173833029 cites W2149441684 @default.
- W3173833029 cites W2158485828 @default.
- W3173833029 cites W2159482845 @default.
- W3173833029 cites W2179438025 @default.
- W3173833029 cites W2197124664 @default.
- W3173833029 cites W2230801460 @default.
- W3173833029 cites W2321872593 @default.
- W3173833029 cites W2323326409 @default.
- W3173833029 cites W2339723519 @default.
- W3173833029 cites W2346937970 @default.
- W3173833029 cites W2476462209 @default.
- W3173833029 cites W2506418499 @default.
- W3173833029 cites W2531099443 @default.
- W3173833029 cites W2565872039 @default.
- W3173833029 cites W2588399447 @default.
- W3173833029 cites W2605738899 @default.
- W3173833029 cites W2612467560 @default.
- W3173833029 cites W2613663785 @default.
- W3173833029 cites W2614443510 @default.
- W3173833029 cites W2749288541 @default.
- W3173833029 cites W2776042838 @default.
- W3173833029 cites W2783551232 @default.
- W3173833029 cites W2789416018 @default.
- W3173833029 cites W2789900707 @default.
- W3173833029 cites W2796153225 @default.
- W3173833029 cites W2992227097 @default.
- W3173833029 cites W3006482814 @default.
- W3173833029 cites W3006500278 @default.
- W3173833029 cites W3012579034 @default.
- W3173833029 cites W4237335579 @default.
- W3173833029 cites W4237351456 @default.
- W3173833029 cites W4294216483 @default.
- W3173833029 doi "https://doi.org/10.1371/journal.pcbi.1009132" @default.
- W3173833029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8281988" @default.
- W3173833029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34214079" @default.
- W3173833029 hasPublicationYear "2021" @default.
- W3173833029 type Work @default.
- W3173833029 sameAs 3173833029 @default.
- W3173833029 citedByCount "7" @default.
- W3173833029 countsByYear W31738330292021 @default.
- W3173833029 countsByYear W31738330292022 @default.
- W3173833029 countsByYear W31738330292023 @default.
- W3173833029 crossrefType "journal-article" @default.
- W3173833029 hasAuthorship W3173833029A5002402867 @default.
- W3173833029 hasAuthorship W3173833029A5011108891 @default.
- W3173833029 hasAuthorship W3173833029A5012343504 @default.
- W3173833029 hasAuthorship W3173833029A5023403433 @default.
- W3173833029 hasAuthorship W3173833029A5033555764 @default.
- W3173833029 hasAuthorship W3173833029A5048568172 @default.
- W3173833029 hasAuthorship W3173833029A5049746620 @default.
- W3173833029 hasAuthorship W3173833029A5062944849 @default.
- W3173833029 hasAuthorship W3173833029A5087046325 @default.
- W3173833029 hasBestOaLocation W31738330291 @default.
- W3173833029 hasConcept C104317684 @default.
- W3173833029 hasConcept C105951970 @default.
- W3173833029 hasConcept C127716648 @default.
- W3173833029 hasConcept C137620995 @default.